Regarding small-cell lung cancer (SCLC), CD9 was expressed preferentially in SCLC tumors and metastases from three of seven relapsed patients, whereas chemonaïve primary tumors from 16 patients were CD9 negative with only one exception (85). Here, CD9 is linked to small cell lung carcinoma.